How does Xultophy work?
Xultophy 100/3.6 contains the active ingredients insulin degludec and liraglutide. Xultophy is used as an add-on to diet and exercise in patients with type 2 diabetes to help improve their blood sugar level control (glycemic control).
Xultophy is injected subcutaneously - under the skin - using an insulin pen. Each millimeter (ml) of Xultophy contains 100 units of insulin degludec and 3.6 mg of liraglutide.
The inactive ingredients in Xultophy are glycerol, phenol, zinc and water for injection.
How does Xultophy work?
Insulin degludec is a long-acting human insulin analog, while liraglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist.
Insulin degludec lowers blood glucose by stimulating skeletal muscle and fat to take up more glucose and by blocking the liver from producing glucose. Insulin helps to prevent fats and other lipids from being broken down (lipolysis) and also helps to prevent the breakdown of proteins (proteolysis). The production of protein is also enhanced by insluin.
Liraglutide, the GLP-1 receptor agonist, belongs to a group of drugs that are also known as incretin mimetics. Liraglutide works by:
Insulin degludec is also the active ingredient in Tresiba and liraglutide is the active ingredient in Victoza and Saxenda.
Related medical questions
- How does Xultophy work?
- How and where should I inject insulin?
- What are the different types of insulin?
- What is the difference between Soliqua and Xultophy?
- How does Xultophy work?
- How and where should I inject insulin?
- What are the different types of insulin?
- What is the difference between Soliqua and Xultophy?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions